INmune Bio

-$0.84 (-6.97%) Today
-$0.22 (-1.96%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE.

CEO
Raymond J. Tesi
Employees
5
Headquarters
Boca Raton, Florida
Founded
2015

INMB Key Statistics

Market cap
200.20M
Price-Earnings ratio
—
Dividend yield
—
Average volume
221.10K
High today
$12.13
Low today
$10.96
Open price
$11.95
Volume
226.28K
52 Week high
$30.37
52 Week low
$8.40

INMB News

Simply Wall StDec 2

Is INmune Bio Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvi

INMB Earnings

-$0.55
-$0.37
-$0.18
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure